Mathieu C, Asbjornsdottir B, Bajaj HS, Lane W, et al. Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial. Lancet 2023 May 5:S0140-6736(23)00520-2. doi: 10.1016/S0140-6736(23)00520.
PMID: 37156252